Canine immune-mediated hemolytic anemia: treatment and prognosis
- PMID: 17726852
Canine immune-mediated hemolytic anemia: treatment and prognosis
Abstract
The treatment of primary immune-mediated hemolytic anemia involves short-term oxygen-carrying support and long-term immunosuppressive therapy. Therapeutic options include blood transfusion, standard and more speculative immunosuppressive agents, splenectomy, and prevention of thromboembolic disease. This article also discusses the prognosis and prognostic indicators.
Comment in
-
Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.Compend Contin Educ Vet. 2007 Apr;29(4):217-25. Compend Contin Educ Vet. 2007. PMID: 17726851 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical